CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Hypera SA Company Snapshot
Hypera SA operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hypera SA with three other pharmaceutical manufacturers in Latin America: Instituto Hermes Pardini SA (2020 sales of 1.49 billion Brazilian Reals [US$266.07 million] of which 100% was auxiliary diagnostic support services), Fleury SA (2.97 billion Brazilian Reals [US$529.22 million] of which 82% was Diagnostic Medicine), and Diagnosticos Da America SA (7.04 billion Brazilian Reals [US$1.25 billion] of which 62% was Outpatient).

Sales Analysis. Hypera SA reported sales of 4.09 billion Brazilian Reals (US$728.19 million) for the year ending December of 2020. This represents an increase of 24.1% versus 2019, when the company's sales were 3.29 billion Brazilian Reals.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Hypera SA
  Stock Performance Chart for Hypera SA
 
  Stock Data: Recent Stock Performance:
  Current Price (4/1/2021): 31.80
(Figures in Brazilian Reals)
1 Week -1.7%   13 Weeks 0.3%  
4 Weeks -7.2%   52 Weeks 10.7%  
 
Hypera SA Key Data:
  Ticker: HYPE3 Country: Brazil
  Exchanges: SOP Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 4,088,871,000
(Year Ending Jan 2021).
Employees: 8,918
  Currency: Brazilian Reals Market Cap: 20,142,480,835
  Fiscal Yr Ends: December Shares Outstanding: 633,411,347
  Share Type: Ordinary Closely Held Shares: 263,198,248
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.